If Ozempic is not a suitable option for you, Boca Medical Care offers a range of evidence-based weight loss methods
All GLP-1 receptor agonists and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Thus, Ozempic represents a shift towards more integrated, holistic management of diabetes, addressing multiple aspects of the disease beyond just glucose control
Convergent evidence across multiple independent sources (clinical trials, academic reviews, medical guidelines, practitioner experience) is stronger than any single source
3.3 Clinical characteristics The reported ADRs included acute kidney injury (AKI), CKD, acute renal failure (ARF), acute interstitial nephritis (AIN), focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), and nephrotic syndrome, with AKI being the most frequent